Architecture of an in vivo-tissue engineered autologous conduit "Biovalve"

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 86, Issue 1, 2008, Pages 1-8

  Hayashida, Kyoko ^a,b   Kanda, Keiichi ^b   Oie, Tomonori ^a,c,d   Okamoto, Yoshihiro ^e   Ishibashi Ueda, Hatsue ^a   Onoyama, Masaaki ^f   Tajikawa, Tsutomu ^a   Ohba, Kenkichi ^f   Yaku, Hitoshi ^b   Nakayama, Yasuhide ^a,d  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Shinkan Kogyo Co   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

^e BRIDGESTONE CORPORATION   (Japan)

^f KANSAI UNIVERSITY   (Japan)

Author keywords

Autologous valve; Biovalve; Conduit; in body tissue architecture; in vivo tissue engineering

Indexed keywords

ARCHITECTURAL DESIGN; CELL CULTURE; CELLS; DATA FLOW ANALYSIS; FIBER OPTICS; HEALTH; MICROFLUIDICS; MOLDS; PAINTING; PLASTICS; POLYMERS; SCAFFOLDS; SUBSTRATES; TECHNOLOGY; TISSUE CULTURE; TISSUE ENGINEERING; TURBULENT FLOW;

3 DIMENSIONAL; ELASTIC FIBERS; FLOW DIRECTIONS; FOREIGN BODY REACTION (FBR); IMMUNOHISTOCHEMICAL STAINING; IN VIVO TISSUE ENGINEERING; IN-VIVO; INFLAMMATORY CELLS; MICRO POROUS; MOLD DESIGNS; PLASTIC SUBSTRATES; POSITIVE CELLS; REGENERATIVE MEDICINES; SMALL APERTURES; TISSUE ARCHITECTURES; TRANSITION PHASE; TUBULAR SCAFFOLD; VALVE MOVEMENT; VIDEO DATA; VIMENTIN;

TISSUE;

ACRYLIC ACID; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; POLYURETHAN; SILICONE; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOGRAFT; DIASTOLE; DIASTOLIC BLOOD PRESSURE; FIBROBLAST; FOREIGN BODY REACTION; HEART VALVE BIOPROSTHESIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MYOFIBROBLAST; NONHUMAN; PRODUCT DEVELOPMENT; PULSATILE FLOW; RABBIT; TISSUE ENGINEERING;

ACTINS; ANIMALS; BIOMEDICAL ENGINEERING; BIOPHYSICS; BIOPROSTHESIS; COLLAGEN; FIBROBLASTS; GUIDED TISSUE REGENERATION; HEART VALVE PROSTHESIS; INFLAMMATION; MUSCLE, SMOOTH; PROSTHESIS DESIGN; RABBITS; TISSUE ENGINEERING; VIMENTIN;

EID: 45749103188     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30981     Document Type: Article

References (32)

1. Rabkin-Aikawa E, Mayer JE Jr, Schoen FJ. Heart valve regeneration. Adv Biochem Engin/Biotechnol 2005;94:141-179.
2. Hoerstrup SP, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT™ in pediatric patients. Eur J Cardiothorac Surg 2003;23:1002-1006.
3. Rieder E, Seebacher G, Kasimir M-T, Eichmair E, Winter B, Dekan B, Wolner E, Simon P, Weigel G. Tissue engineering of heart valves. Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005;111:2792-2797.
4. Bader A, Steinhoff G, Strobl K, Schilling T, Brandes G, Mertsching H, Tsikas D, Froelich J, Haverich A. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation 2000;70:7-14.
5. Cebotari S, Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A Construction of autologous human heart valves based on an acellular allograft matrix. Circulation 2002;106(12, Suppl 1):I63-I68.
6. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation 2000;102(19, Suppl 3):III44-III49.
7. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering heart valves: Valve leaflet replacement study in a lamb model. Ann Thorac Surg 1995;60:S513-S516.
8. Mol A, Rutten MC, Driessen NJ, Bouten CV, Zund G, Baaijens FP, Hoerstrup SP. Autologous human tissue-engineered heart valves: Prospects for systemic application. Circulation 2006;114(1, Suppl I):I152-I158.
9. Hilbert SL, Yanagida R, Souza J, Wolfinbarger L, Jones AL, Krueger P, Stearns G, Bert A, Hopkins RA. Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep. J Heart Valve Dis 2004;13:831-840.
10. Steinhoff G, Stock U, Karim N, Mertsching H, Timke A, Meliss RR, Pethig K, Haverich A, Bader A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: In vivo restoration of valve tissue. Circulation 2000;102(19, Suppl 3):III50-III55.
11. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996;94(9, Suppl):II164-II168.
12. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valve leaflets: Does cell origin affect outcome? Circulation 1997;96(9, Suppl):II102-II107.
13. Dohmen PM, Lembcke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue-engineered heart valve. Ann Thorac Surg 2002;74:1438-1442.
14. Stock UA, Nagashima M, Khalil PN, Nollert GD, Herden T, Sperling JS, Moran A, Lien J, Martin DP, Schoen FJ, Vacanti JP, Mayer JE Jr. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg 2000;119:732-740.
15. Cebotari S, Lichtenberg A, Tudirache I, Hilfiker A, Mertsching H, Leyh R, Breymann T, Kallenbach K, Maniuc L, Batrinac A, Repin O, Maliga O, Ciubotaru A, Haverich A Clinical application of tissue engineered human heart valves using autologous progenitor cells. Circulation 2006; 114(1, Suppl):I132-I137.
16. Lee WJ, Park BY. The subcutaneous capsules for Foreign body in fetal rabbits: Preliminary report. Yonsei Med J 2001;42:595-601.
17. Badid C, Mounter N, Costa AMA, Desmouliere A. Role of myofibroblasts during normal tissue repair and excessive scarring: Interest of their assessment in nephropathies. Histol Histopathol 2000;15:269-280.
18. Sparks CH, Silicone mandril method of femoropopliteal artery bypass. Clinical experience and surgical technics. Am J Surg 1972;124:244-249.
19. Hallin RW, Sweetman WR. The sparkes' mandril graft. A seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates. Am J Surg 1976;132:221-223.
20. Campbell JH, Efendy J, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res 1999;85:1173-1178.
21. Campbell JH, Efendy JL, Han C, Girjes AA, Campbell GR. Haemopoetic origin of myofibroblasts formed in the peritoneal cavity in response to a foreign body. J Vasc Res 2000;37:364-371.
22. Flameng W. A new approach to heart valve tissue engineering. Int J Cardiol 95:S55-S56, 2004.
23. De Visscher G, Verbeken E, Van Kerrebroeck C, Holvoet P, Flameng W. Recellularization of photo-oxidised pericardium using immature foreign body reaction in the construction of a tissue engineered heart vlave. J Mol Cell Cardiol 2004;37:214.
24. Nakayama Y, Ishibashi-Ueda H, Takamizawa K. In vivo tissue-engineered small-caliber arterial graft prosthesis consisting of autologous tissue (Biotube). Cell Transplant 2004;13:439-449.
25. Hayashida K, Kanda K, Yaku H, Ando J, Nakayama Y. Development of an in vivo tissue-engineered autologoue heart valve (the Biovalve): Preparation of prototype model. J Thorac Cardiovasc Surg 2007;134:152-159.
26. Sakai O, Kanda K, Ishibashi-Ueda H, Takamizawa K, Ametani A, Yaku H, Nakayama Y. Development of the wing-attached rod for acceleration of "Biotube" vascular grafts fabrication in vivo. J Biomed Mater Res B Appl Biomater 2007;83:240-247.
27. Sakai O, Kanda K, Yaku H, Sato T, Nakayama Y. Tissue organization acceleration technology in vivo in regenerative medicine: Promotion of angiogenesis by control-released nicotine. Artif Organs 2005;29:780.
28. Watanabe T, Sakai O, Hayashida K, Okamoto Y, Nemoto Y, Kanda K, Yaku H, Nakayama Y. In vivo tissue-engineered autologous small-caliber vascular grafts "Biotubes": Autonomical regeneration to the structural vessel wall after implantation. Circulation 2006:144(Suppl 2):11-34.
29. L'Heureux N, Dusserre N, Konig G, Victor B, Keire P, Wight TN, Chronos NA, Kyles AE, Gregory CR, Hoyt G, Robbins RC, McAllister TN. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006;12:316-365.
30. Flanagen TC, Cornelissen C, Koch S, Tschoeke B, Sachweh JS, Schmiyz-Rode T, Jockenhoevel S. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimized dynamic conditioning. Biomaterials 2007;28:3388-3397.
31. Tranquillo RT, Hills A, Girton TS, Grove M, Neidert M. Tissuequivalent approach to a tissue-engineered cardiovascular valve. US Patent 6,666,886 B1; December 2003.
32. Neidert MR, Tranquillo RT, Tissue-engineered valves with commerssural alignment. Tissue Eng 2006:12:891-903.